APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metabotropic Glutamate Receptor 2

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Metabotropic Glutamate Receptor 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025186 pages

Choose your research edition.

Industry ResearchMetabotropic Glutamate Receptor 2 Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Metabotropic Glutamate Receptor 2 Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Metabotropic Glutamate Receptor 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metabotropic Glutamate Receptor 2 Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Metabotropic Glutamate Receptor 2 Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Metabotropic Glutamate Receptor 2 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Metabotropic Glutamate Receptor 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Metabotropic Glutamate Receptor 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Metabotropic Glutamate Receptor 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Metabotropic Glutamate Receptor 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Metabotropic Glutamate Receptor 2 include Johnson & Johnson, Merck & Co Inc, Eli Lilly and Company, Domain Therapeutics SA, Denovo Biopharma LLC, Bristol-Myers Squibb Company and Addex Therapeutics Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Metabotropic Glutamate Receptor 2 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Metabotropic Glutamate Receptor 2 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Metabotropic Glutamate Receptor 2 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Metabotropic Glutamate Receptor 2 market size, projected growth trends, production technologies, key applications, and end-use industries.

Metabotropic Glutamate Receptor 2 Segment by Company

Johnson & Johnson

Merck & Co Inc

Eli Lilly and Company

Domain Therapeutics SA

Denovo Biopharma LLC

Bristol-Myers Squibb Company

Addex Therapeutics Ltd

Metabotropic Glutamate Receptor 2 Segment by Type

LY-2607540

JNJ-40411813

DT-2442

BMT-133218

Others

Metabotropic Glutamate Receptor 2 Segment by Application

Depression

Chronic Pain

Schizophrenia

Anxiety Disorders

Others

Metabotropic Glutamate Receptor 2 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metabotropic Glutamate Receptor 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metabotropic Glutamate Receptor 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metabotropic Glutamate Receptor 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Metabotropic Glutamate Receptor 2 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Metabotropic Glutamate Receptor 2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Metabotropic Glutamate Receptor 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Metabotropic Glutamate Receptor 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Metabotropic Glutamate Receptor 2 Industry Trends Table 2. Metabotropic Glutamate Receptor 2 Industry Drivers Table 3. Metabotropic Glutamate Receptor 2 Industry Opportunities and Challenges Table 4. Metabotropic Glutamate Receptor 2 Industry Restraints Table 5. Global Metabotropic Glutamate Receptor 2 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Metabotropic Glutamate Receptor 2 Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Manufacturers Table 9. Global Metabotropic Glutamate Receptor 2 Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Metabotropic Glutamate Receptor 2 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Metabotropic Glutamate Receptor 2 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Metabotropic Glutamate Receptor 2 Manufacturers, Product Type & Application Table 13. Global Metabotropic Glutamate Receptor 2 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Metabotropic Glutamate Receptor 2 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of LY-2607540 Table 17. Major Manufacturers of JNJ-40411813 Table 18. Major Manufacturers of DT-2442 Table 19. Major Manufacturers of BMT-133218 Table 20. Major Manufacturers of Others Table 21. Global Metabotropic Glutamate Receptor 2 Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 22. Global Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026) & (W Units) Table 23. Global Metabotropic Glutamate Receptor 2 Sales by Type (2027-2032) & (W Units) Table 24. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2021-2026) Table 25. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2027-2032) Table 26. Global Metabotropic Glutamate Receptor 2 Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 27. Global Metabotropic Glutamate Receptor 2 Revenue by Type (2021-2026) & (W Units) Table 28. Global Metabotropic Glutamate Receptor 2 Revenue by Type (2027-2032) & (W Units) Table 29. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2021-2026) Table 30. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Depression Table 32. Major Manufacturers of Chronic Pain Table 33. Major Manufacturers of Schizophrenia Table 34. Major Manufacturers of Anxiety Disorders Table 35. Major Manufacturers of Others Table 36. Global Metabotropic Glutamate Receptor 2 Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026) & (W Units) Table 38. Global Metabotropic Glutamate Receptor 2 Sales by Application (2027-2032) & (W Units) Table 39. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2021-2026) Table 40. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2027-2032) Table 41. Global Metabotropic Glutamate Receptor 2 Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 42. Global Metabotropic Glutamate Receptor 2 Revenue by Application (2021-2026) & (W Units) Table 43. Global Metabotropic Glutamate Receptor 2 Revenue by Application (2027-2032) & (W Units) Table 44. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2021-2026) Table 45. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2027-2032) Table 46. Global Metabotropic Glutamate Receptor 2 Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 47. Global Metabotropic Glutamate Receptor 2 Sales by Region (2021-2026) & (W Units) Table 48. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2021-2026) Table 49. Global Metabotropic Glutamate Receptor 2 Sales Forecasted by Region (2027-2032) & (W Units) Table 50. Global Metabotropic Glutamate Receptor 2 Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Metabotropic Glutamate Receptor 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. North America Metabotropic Glutamate Receptor 2 Sales by Country (2021-2026) & (W Units) Table 53. North America Metabotropic Glutamate Receptor 2 Sales by Country (2027-2032) & (W Units) Table 54. Europe Metabotropic Glutamate Receptor 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Europe Metabotropic Glutamate Receptor 2 Sales by Country (2021-2026) & (W Units) Table 56. Europe Metabotropic Glutamate Receptor 2 Sales by Country (2027-2032) & (W Units) Table 57. Asia Pacific Metabotropic Glutamate Receptor 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. Asia Pacific Metabotropic Glutamate Receptor 2 Sales by Country (2021-2026) & (W Units) Table 59. Asia Pacific Metabotropic Glutamate Receptor 2 Sales by Country (2027-2032) & (W Units) Table 60. South America, Middle East and Africa Metabotropic Glutamate Receptor 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 61. South America, Middle East and Africa Metabotropic Glutamate Receptor 2 Sales by Country (2021-2026) & (W Units) Table 62. South America, Middle East and Africa Metabotropic Glutamate Receptor 2 Sales by Country (2027-2032) & (W Units) Table 63. Global Metabotropic Glutamate Receptor 2 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Metabotropic Glutamate Receptor 2 Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Metabotropic Glutamate Receptor 2 Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Region (2021-2026) Table 67. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Region (2027-2032) Table 68. Johnson & Johnson Company Information Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Johnson & Johnson Metabotropic Glutamate Receptor 2 Product Portfolio Table 72. Johnson & Johnson Recent Development Table 73. Merck & Co Inc Company Information Table 74. Merck & Co Inc Business Overview Table 75. Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Merck & Co Inc Metabotropic Glutamate Receptor 2 Product Portfolio Table 77. Merck & Co Inc Recent Development Table 78. Eli Lilly and Company Company Information Table 79. Eli Lilly and Company Business Overview Table 80. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product Portfolio Table 82. Eli Lilly and Company Recent Development Table 83. Domain Therapeutics SA Company Information Table 84. Domain Therapeutics SA Business Overview Table 85. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product Portfolio Table 87. Domain Therapeutics SA Recent Development Table 88. Denovo Biopharma LLC Company Information Table 89. Denovo Biopharma LLC Business Overview Table 90. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product Portfolio Table 92. Denovo Biopharma LLC Recent Development Table 93. Bristol-Myers Squibb Company Company Information Table 94. Bristol-Myers Squibb Company Business Overview Table 95. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product Portfolio Table 97. Bristol-Myers Squibb Company Recent Development Table 98. Addex Therapeutics Ltd Company Information Table 99. Addex Therapeutics Ltd Business Overview Table 100. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product Portfolio Table 102. Addex Therapeutics Ltd Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Metabotropic Glutamate Receptor 2 Distributors List Table 106. Metabotropic Glutamate Receptor 2 Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Metabotropic Glutamate Receptor 2 Product Image Figure 2. Global Metabotropic Glutamate Receptor 2 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metabotropic Glutamate Receptor 2 Market Size (2021-2032) & (US$ Million) Figure 4. Global Metabotropic Glutamate Receptor 2 Sales (2021-2032) & (W Units) Figure 5. Global Metabotropic Glutamate Receptor 2 Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Metabotropic Glutamate Receptor 2 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. LY-2607540 Image Figure 9. JNJ-40411813 Image Figure 10. DT-2442 Image Figure 11. BMT-133218 Image Figure 12. Others Image Figure 13. Global Metabotropic Glutamate Receptor 2 Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Metabotropic Glutamate Receptor 2 Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2021-2032) Figure 16. Global Metabotropic Glutamate Receptor 2 Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 17. Global Metabotropic Glutamate Receptor 2 Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2021-2032) Figure 19. Depression Image Figure 20. Chronic Pain Image Figure 21. Schizophrenia Image Figure 22. Anxiety Disorders Image Figure 23. Others Image Figure 24. Global Metabotropic Glutamate Receptor 2 Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 25. Global Metabotropic Glutamate Receptor 2 Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2021-2032) Figure 27. Global Metabotropic Glutamate Receptor 2 Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 28. Global Metabotropic Glutamate Receptor 2 Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2021-2032) Figure 30. North America Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 31. North America Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2021-2032) Figure 32. U.S. Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Canada Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Mexico Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Europe Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2021-2032) Figure 37. Germany Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 38. France Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 39. U.K. Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Italy Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Netherlands Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Asia Pacific Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Asia Pacific Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2021-2032) Figure 44. China Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Japan Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South Korea Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 47. Southeast Asia Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 48. India Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Australia Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 50. South America, Middle East and Africa Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 51. South America, Middle East and Africa Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2021-2032) Figure 52. Brazil Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 53. South Africa Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Saudi Arabia Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Turkey Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Argentina Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 57. UAE Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 58. Egypt Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 59. Chile Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 60. Global Metabotropic Glutamate Receptor 2 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Figure 63. North America Metabotropic Glutamate Receptor 2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Figure 65. Europe Metabotropic Glutamate Receptor 2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Metabotropic Glutamate Receptor 2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Metabotropic Glutamate Receptor 2 Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Metabotropic Glutamate Receptor 2 Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • LY-2607540
  • JNJ-40411813
  • DT-2442
  • BMT-133218
  • Others
Applications
  • Depression
  • Chronic Pain
  • Schizophrenia
  • Anxiety Disorders
  • Others
Companies covered
  • Johnson & Johnson
  • Merck & Co Inc
  • Eli Lilly and Company
  • Domain Therapeutics SA
  • Denovo Biopharma LLC
  • Bristol-Myers Squibb Company
  • Addex Therapeutics Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Metabotropic Glutamate Receptor 2 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Metabotropic Glutamate Receptor 2 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Metabotropic Glutamate Receptor 2 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Metabotropic Glutamate Receptor 2 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Metabotropic Glutamate Receptor 2 Market Dynamics
  1. 2.1 Metabotropic Glutamate Receptor 2 Industry Trends
  2. 2.2 Metabotropic Glutamate Receptor 2 Industry Drivers
  3. 2.3 Metabotropic Glutamate Receptor 2 Industry Opportunities and Challenges
  4. 2.4 Metabotropic Glutamate Receptor 2 Industry Restraints
3 Metabotropic Glutamate Receptor 2 Market by Manufacturers
  1. 3.1 Global Metabotropic Glutamate Receptor 2 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Metabotropic Glutamate Receptor 2 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Metabotropic Glutamate Receptor 2 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Metabotropic Glutamate Receptor 2 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Metabotropic Glutamate Receptor 2 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Metabotropic Glutamate Receptor 2 Manufacturers, Product Type & Application
  7. 3.7 Global Metabotropic Glutamate Receptor 2 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Metabotropic Glutamate Receptor 2 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Metabotropic Glutamate Receptor 2 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Metabotropic Glutamate Receptor 2 Tier 1, Tier 2, and Tier 3
4 Metabotropic Glutamate Receptor 2 Market by Type
  1. 4.1 Metabotropic Glutamate Receptor 2 Type Introduction
  2. 4.1.1 LY-2607540
  3. 4.1.2 JNJ-40411813
  4. 4.1.3 DT-2442
  5. 4.1.4 BMT-133218
  6. 4.1.5 Others
  7. 4.2 Global Metabotropic Glutamate Receptor 2 Sales by Type
  8. 4.2.1 Global Metabotropic Glutamate Receptor 2 Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Metabotropic Glutamate Receptor 2 Sales by Type (2021-2032)
  10. 4.2.3 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2021-2032)
  11. 4.3 Global Metabotropic Glutamate Receptor 2 Revenue by Type
  12. 4.3.1 Global Metabotropic Glutamate Receptor 2 Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Metabotropic Glutamate Receptor 2 Revenue by Type (2021-2032)
  14. 4.3.3 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2021-2032)
5 Metabotropic Glutamate Receptor 2 Market by Application
  1. 5.1 Metabotropic Glutamate Receptor 2 Application Introduction
  2. 5.1.1 Depression
  3. 5.1.2 Chronic Pain
  4. 5.1.3 Schizophrenia
  5. 5.1.4 Anxiety Disorders
  6. 5.1.5 Others
  7. 5.2 Global Metabotropic Glutamate Receptor 2 Sales by Application
  8. 5.2.1 Global Metabotropic Glutamate Receptor 2 Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Metabotropic Glutamate Receptor 2 Sales by Application (2021-2032)
  10. 5.2.3 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2021-2032)
  11. 5.3 Global Metabotropic Glutamate Receptor 2 Revenue by Application
  12. 5.3.1 Global Metabotropic Glutamate Receptor 2 Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Metabotropic Glutamate Receptor 2 Revenue by Application (2021-2032)
  14. 5.3.3 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2021-2032)
6 Global Metabotropic Glutamate Receptor 2 Sales by Region
  1. 6.1 Global Metabotropic Glutamate Receptor 2 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Metabotropic Glutamate Receptor 2 Sales by Region (2021-2032)
  3. 6.2.1 Global Metabotropic Glutamate Receptor 2 Sales by Region (2021-2026)
  4. 6.2.2 Global Metabotropic Glutamate Receptor 2 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Metabotropic Glutamate Receptor 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Metabotropic Glutamate Receptor 2 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Metabotropic Glutamate Receptor 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Metabotropic Glutamate Receptor 2 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Metabotropic Glutamate Receptor 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Metabotropic Glutamate Receptor 2 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Metabotropic Glutamate Receptor 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Metabotropic Glutamate Receptor 2 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Metabotropic Glutamate Receptor 2 Revenue by Region
  1. 7.1 Global Metabotropic Glutamate Receptor 2 Revenue by Region
  2. 7.1.1 Global Metabotropic Glutamate Receptor 2 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Metabotropic Glutamate Receptor 2 Revenue by Region (2021-2026)
  4. 7.1.3 Global Metabotropic Glutamate Receptor 2 Revenue by Region (2027-2032)
  5. 7.1.4 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Metabotropic Glutamate Receptor 2 Revenue (2021-2032)
  8. 7.2.2 North America Metabotropic Glutamate Receptor 2 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Metabotropic Glutamate Receptor 2 Revenue (2021-2032)
  11. 7.3.2 Europe Metabotropic Glutamate Receptor 2 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Metabotropic Glutamate Receptor 2 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Metabotropic Glutamate Receptor 2 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Metabotropic Glutamate Receptor 2 Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Merck & Co Inc
  8. 8.2.1 Merck & Co Inc Company Information
  9. 8.2.2 Merck & Co Inc Business Overview
  10. 8.2.3 Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co Inc Metabotropic Glutamate Receptor 2 Product Portfolio
  12. 8.2.5 Merck & Co Inc Recent Developments
  13. 8.3 Eli Lilly and Company
  14. 8.3.1 Eli Lilly and Company Company Information
  15. 8.3.2 Eli Lilly and Company Business Overview
  16. 8.3.3 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product Portfolio
  18. 8.3.5 Eli Lilly and Company Recent Developments
  19. 8.4 Domain Therapeutics SA
  20. 8.4.1 Domain Therapeutics SA Company Information
  21. 8.4.2 Domain Therapeutics SA Business Overview
  22. 8.4.3 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product Portfolio
  24. 8.4.5 Domain Therapeutics SA Recent Developments
  25. 8.5 Denovo Biopharma LLC
  26. 8.5.1 Denovo Biopharma LLC Company Information
  27. 8.5.2 Denovo Biopharma LLC Business Overview
  28. 8.5.3 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product Portfolio
  30. 8.5.5 Denovo Biopharma LLC Recent Developments
  31. 8.6 Bristol-Myers Squibb Company
  32. 8.6.1 Bristol-Myers Squibb Company Company Information
  33. 8.6.2 Bristol-Myers Squibb Company Business Overview
  34. 8.6.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product Portfolio
  36. 8.6.5 Bristol-Myers Squibb Company Recent Developments
  37. 8.7 Addex Therapeutics Ltd
  38. 8.7.1 Addex Therapeutics Ltd Company Information
  39. 8.7.2 Addex Therapeutics Ltd Business Overview
  40. 8.7.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product Portfolio
  42. 8.7.5 Addex Therapeutics Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Metabotropic Glutamate Receptor 2 Value Chain Analysis
  2. 9.1.1 Metabotropic Glutamate Receptor 2 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Metabotropic Glutamate Receptor 2 Production Mode & Process
  6. 9.2 Metabotropic Glutamate Receptor 2 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Metabotropic Glutamate Receptor 2 Distributors
  9. 9.2.3 Metabotropic Glutamate Receptor 2 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst